Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Novel compound heterozygous mutations in MYO7A in a Chinese family with Usher syndrome type 1.

Publication ,  Journal Article
Liu, F; Li, P; Liu, Y; Li, W; Wong, F; Du, R; Wang, L; Li, C; Jiang, F; Tang, Z; Liu, M
Published in: Mol Vis
2013

PURPOSE: To identify the disease-causing mutation(s) in a Chinese family with autosomal recessive Usher syndrome type 1 (USH1). METHODS: An ophthalmic examination and an audiometric test were conducted to ascertain the phenotype of two affected siblings. The microsatellite marker D11S937, which is close to the candidate gene MYO7A (USH1B locus), was selected for genotyping. From the DNA of the proband, all coding exons and exon-intron boundaries of MYO7A were sequenced to identify the disease-causing mutation(s). Restriction fragment length polymorphism (RFLP) analysis was performed to exclude the alternative conclusion that the mutations are non-pathogenic rare polymorphisms. RESULTS: Based on severe hearing impairment, unintelligible speech, and retinitis pigmentosa, a clinical diagnosis of Usher syndrome type 1 was made. The genotyping results did not exclude the USH1B locus, which suggested that the MYO7A gene was likely the gene associated with the disease-causing mutation(s) in the family. With direct DNA sequencing of MYO7A, two novel compound heterozygous mutations (c.3742G>A and c.6051+1G>A) of MYO7A were identified in the proband. DNA sequence analysis and RFLP analysis of other family members showed that the mutations cosegregated with the disease. Unaffected members, including the parents, uncle, and sister of the proband, carry only one of the two mutations. The mutations were not present in the controls (100 normal Chinese subjects=200 chromosomes) according to the RFLP analysis. CONCLUSIONS: In this study, we identified two novel mutations, c.3742G>A (p.E1248K) and c.6051+1G>A (donor splice site mutation in intron 44), of MYO7A in a Chinese non-consanguineous family with USH1. The mutations cosegregated with the disease and most likely cause the phenotype in the two affected siblings who carry these mutations compound heterozygously. Our finding expands the mutational spectrum of MYO7A.

Duke Scholars

Published In

Mol Vis

EISSN

1090-0535

Publication Date

2013

Volume

19

Start / End Page

695 / 701

Location

United States

Related Subject Headings

  • Usher Syndromes
  • Sequence Alignment
  • Pedigree
  • Ophthalmology & Optometry
  • Myosins
  • Myosin VIIa
  • Mutation
  • Molecular Sequence Data
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, F., Li, P., Liu, Y., Li, W., Wong, F., Du, R., … Liu, M. (2013). Novel compound heterozygous mutations in MYO7A in a Chinese family with Usher syndrome type 1. Mol Vis, 19, 695–701.
Liu, Fei, Pengcheng Li, Ying Liu, Weirong Li, Fulton Wong, Rong Du, Lei Wang, et al. “Novel compound heterozygous mutations in MYO7A in a Chinese family with Usher syndrome type 1.Mol Vis 19 (2013): 695–701.
Liu F, Li P, Liu Y, Li W, Wong F, Du R, et al. Novel compound heterozygous mutations in MYO7A in a Chinese family with Usher syndrome type 1. Mol Vis. 2013;19:695–701.
Liu F, Li P, Liu Y, Li W, Wong F, Du R, Wang L, Li C, Jiang F, Tang Z, Liu M. Novel compound heterozygous mutations in MYO7A in a Chinese family with Usher syndrome type 1. Mol Vis. 2013;19:695–701.

Published In

Mol Vis

EISSN

1090-0535

Publication Date

2013

Volume

19

Start / End Page

695 / 701

Location

United States

Related Subject Headings

  • Usher Syndromes
  • Sequence Alignment
  • Pedigree
  • Ophthalmology & Optometry
  • Myosins
  • Myosin VIIa
  • Mutation
  • Molecular Sequence Data
  • Male
  • Humans